ArticleBMJ (Clinical research ed.)2025
First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.
Article in BMJ (Clinical research ed.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.European urology open science · 2026Article
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.World journal of surgical oncology · 2026Article
- Cancer statistics, 2026: divergent trends and the implementation gap.Nature reviews. Clinical oncology · 2026Article
- Breast cancer mortality among women who have attended BreastScreen Norway, 1996-2023.Breast cancer research : BCR · 2026Article
- Accelerating global efforts to prevent women's cancers.Military Medical Research · 2026Article
- EXPRESSION OF CONCERN: First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.BMJ (Clinical research ed.) · 2025Article
Corrections and comments
- Commented on by
- Expression of concern
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine whether women who did not attend their first mammography screening invitation have a long term risk of poor screening adherence and breast cancer outcomes.
designPopulation based cohort study.
settingStockholm, Sweden.
participants432 775 women who received invitations to the Swedish Mammography Screening Programme between 1991 and 2020 and were initially invited at either 50 years of age or 40 years of age.
main outcome measuresScreening adherence, breast cancer incidence, tumour characteristics, and breast cancer mortality tracked through linkage to multiple Swedish national registers, with follow-up until 2023 (up to 25 year follow-up period). Cumulative breast cancer incidences were calculated from first screening participation. Cox proportional hazards models estimated hazard ratios for breast cancer mortality; logistic regression models assessed associations with tumour characteristics by odds ratios.
resultsDuring a total of 4 940 375 person years of follow-up, 16 059 new cases of breast cancer were documented. Among women invited to their first mammography screening, 32.1% (n=138 760) did not participate. These non-participants were persistently less likely to attend subsequent screenings and were more likely have symptom detected, advanced stage breast cancer diagnosed. Specifically, compared with first screening participants, non-participants had an odds ratio of 1.53 (95% confidence interval 1.24 to 1.88) for stage III cancer (160 (4.1%)
conclusionsThis study shows that first screening non-participants represent a large population at long term risk of dying from breast cancer, providing an opportunity for targeted interventions to improve adherence to screening and thereby decrease mortality risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.